Screening for cancer: What's new?;Actualites dans le depistage des cancers

Bulletin du Cancer

Volumn 87, Issue 3, 2000, Pages 239-243

  Sasco, Annie J ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Epidemiology; Screening

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER SCREENING; COLORECTAL CANCER; HUMAN; LUNG CANCER; NEUROBLASTOMA; OVARY CANCER; PROSTATE CANCER; REVIEW; UTERUS CANCER; AGE; BREAST TUMOR; COLON TUMOR; FEMALE; LUNG TUMOR; MALE; MAMMOGRAPHY; MASS SCREENING; METHODOLOGY; NEOPLASM; ORGANIZATION AND MANAGEMENT; OVARY TUMOR; PAPILLOMA VIRUS; PROSTATE TUMOR; RECTUM TUMOR; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

AGE FACTORS; BREAST NEOPLASMS; COLONIC NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MAMMOGRAPHY; MASS SCREENING; NEOPLASMS; NEUROBLASTOMA; OVARIAN NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSTATIC NEOPLASMS; RECTAL NEOPLASMS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0034050718     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. National Institutes of Health Consensus Development Panel. National Institutes of health consensus development conference statement : breast cancer screening for women ages 40-49, January 21-23, 1997. J Natl Cancer Inst Monogr 1997 ; 22 : vii-xviii.
2. Eisinger F, Geller G, Burke W, Holtzman NA. Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. Lancet 1999 ; 353 : 919-20.
3. Kerlikowske K. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years : comparison of relative and absolute benefit. J Natl Cancer Inst Monogr 1997 ; 22 : 79-86.
4. Wright CJ, Mueller CB. Screening mammography and public health policy : the need for perspective. Lancet 1995 ; 346 : 29-32.
5. Cervical cancer screening programs. Can Med Assoc J 1976 ; 114 : 1003-33.
6. Clarke EA, Anderson TW. Does screening by « Pap » smear help prevent cervical cancer ? A case-control study. Lancet 1979 ; ii : 1-4.
7. Cava M, Greenberg M, Fitch M, Spaner D, Taylor K. Towards an inclusive cervical cancer screening strategy : approaches for reaching socioeconomically disadvantaged women. Can Oncol Nurs J 1997 ; 7 : 14-8.
8. Fylan F. Screening for cervical cancer : a review of women's attitudes, knowledge, and behaviour. Br J Gen Pract 1998 ; 48 : 1509-14.
9. Katz A. Cervical cancer screening : role of family physicians. Can Fam Physician 1998 ; 44 : 1661-5.
10. Walsh JME. Cervical cancer : developments in screening and evaluation of the abnormal Pap smear. West J Med 1998 ; 169 : 304-10.
11. Parkin DM, Sankaranarayanan R. Prevention of cervical cancer in developing countries. Thai J Obstet Gynecol 1999 ; 11 : 3-20.
12. Baldauf JJ, Dreyfus M, Ritter J, Meyer P, Philippe E. Cervicography : does it improve cervical cancer screening ? Acta Cytol 1997 ; 41 : 295-301.
13. Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, Alfaro M, Bratti MC, et al. Utility of liquid-based cytology for cervical carcinoma screening : results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer 1999 ; 87 : 48-55.
14. Banda-Gamboa H, Ricketts I, Cairns A, Hussein K, Tucker JH, Husain N. Automation in cervical cytology : an overview. Anal Cell Pathol 1992 ; 4 : 25-48.
15. Williams GH, Romanowski P, Morris L, Madine M, Mills AD, Stoeber K, et al. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci USA 1998 ; 95 : 14932-7.
16. International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 64. Human papilloma viruses. Lyon : International Agency for Research on Cancer, 1995.
17. Rozendaal L, Walboomers JM, van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst TH, et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 1996 ; 68 : 766-9.
18. Jenkins D, Sherlaw-Johnson C, Gallivan S. Can papilloma virus testing be used to improve cervical cancer screening ? Int J Cancer 1996 ; 15 : 768-73.
19. Sigurdsson K. Cervical cancer, Pap smear and HPV testing : an update of the role of organized Pap smear screening and HPV testing. Acta Obstet Cynecol Scand 1999 ; 78 : 467-77.
20. Marcus AC, Crane LA. A review of cervical cancer screening intervention research : implications for public health programs and future research. Prev Med 1998 ; 27 : 13-31.
21. Ménégoz F, Chérié-Challine L. Le cancer en France : incidence et mortalité. Paris : Documentation française, 1998.
22. Faivre J, Tazi MA, El Mrini T, Lejeune C, Benhamiche AM, Dassonville F. Faecal occult blood screening and reduction of colorectal cancer mortality : a case-control study. Br J Cancer 1999 ; 79 : 680-3.
23. Dubois G. Rapport au ministre délégué à la Santé sur le dépistage du cancer du côlon et du rectum en France. Paris, 1995.
24. Agence nationale d'accréditation et d'évaluation en santé. Prévention, dépistage et prise en charge des cancers du côlon. Texre court de la conférence de consensus. Presse Méd 1998 ; 27 : 1283-9.
25. Bond JH. Improving the effectiveness of fecal occult blood screening for colorectal cancer. J Natl Cancer Inst 1999 ; 91 : 1602-3.
26. Austoker J. Screening for colorectal cancer. Br Med J 1994 ; 309 : 382-6.
27. Selby JV, Friedman GD, Queensberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992 ; 326 : 653-7.
28. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal mortality. J Natl Cancer Inst 1992 ; 84 : 1572-5.
29. Khullar SK, Di Sario JA. Colon cancer screening : sigmoidoscopy or colonoscopy. Gastrointest Endosc Clin N Am 1997 ; 7 : 365-86.
30. Bell R, Petticrew M, Luengo S, Sheldon TA. Screening for ovarian cancer : a systematic review. Health Technol Assess 1998 ; 2 : 1-80.
31. McDonald ND, Jacobs IJ. Is there a place for screening in ovarian cancer ? Europ J Obst Gynecol 1999 ; 82 : 155-7.
32. Smart CR. The results of prostate carcinoma screening in the US as reflected in the surveillance, epidemiology and end results. Cancer 1997 ; 80 : 1835-44.
33. Parkes C, Wald NJ, Murphy P, George L, Watt HC, Kirby R, et al. Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer. Br Med J 1995 ; 311 : 1340-3.
34. Rietbergen JB, Schröder FH. Screening for prostate cancer : more questions than answers. Acta Oncol 1998 ; 37 : 515-32.
35. Jacobsen SJ, Bergstralh EJ, Katusik SK, Guess HA, Darby CH, Silverstein MD, et al. Screening digital rectal examination and prostate cancer mortality : a population-based case-control study. Urology 1998 ; 52 : 173-9.
36. Strauss GM, Dominioni L. Lung cancer screening and the surgical oncologist : the controversy. Surg Oncol Clinics N Am 1999 ; 8 : 371-87.
37. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early lung cancer action project : overall design and findings from baseline screening. Lancet 1999 ; 354 : 99-105.
38. Ross JA, Davies SM. Screening for neuroblastoma : progress and pitfalls. Cancer Epidemiol Biomarkers Prev 1999 ; 8 : 189-94.
39. Report of the 1998 consensus conference on neuroblastoma screening. Med Ped Oncol 1999 ; 33 : 357-9.